{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:43:27Z","timestamp":1742913807247,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":54,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642812514"},{"type":"electronic","value":"9783642812491"}],"license":[{"start":{"date-parts":[[1978,1,1]],"date-time":"1978-01-01T00:00:00Z","timestamp":252460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1978,1,1]],"date-time":"1978-01-01T00:00:00Z","timestamp":252460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1978]]},"DOI":"10.1007\/978-3-642-81249-1_5","type":"book-chapter","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T09:54:21Z","timestamp":1326707661000},"page":"28-40","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic Factors and Treatment of Multiple Myeloma: Interest of a Cyclic Sequential Chemohormonotherapy Combining Cyclophosphamide, Melphalan, and Prednisone"],"prefix":"10.1007","author":[{"given":"D.","family":"Belpomme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pouillart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Amor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Feuilhade","family":"De Chauvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Belpomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Menkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Delrieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Depierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Le Mevel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Serrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Delbarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Math\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5_CR1","first-page":"345","volume":"59","author":"DS Alberts","year":"1975","unstructured":"Alberts, D. S., Salmon, S. E. : Adriamycin (NSC-12127) in the treatment of alkylator-resistant multiple myeloma: a pilot study. Cancer Chemother. Rep. 59, 345\u2013350 (1975)","journal-title":"Cancer Chemother. Rep"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0140-6736(76)92710-0","volume":"I","author":"DS Alberts","year":"1976","unstructured":"Alberts, D. S., Durie, B. G. M., Salmon, S. E. : Doxorubicin\/BCNU chemotherapy for multiple myeloma in relapse. Lancet 1976 I, 926\u2013928","journal-title":"Lancet"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V31.1.1.1","volume":"31","author":"R Alexanian","year":"1968","unstructured":"Alexanian, R., Bergsagel, D., Migliore, P., Vaughan, W., Howe, C. D. : Melphalan therapy for plasma cell myeloma. Blood 31,1 (1968)","journal-title":"Blood"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1001\/jama.1969.03160090040009","volume":"208","author":"R Alexanian","year":"1969","unstructured":"Alexanian, R., Haut, A., Khan, A. V., Lane, M., McKelvey, E. M., Migliore, P. J., Stuckey, W. J., Wilson, H. E. : Treatment for multiple myeloma: combination chemotherapy with different melphalan dose regimens. J.A.M.A. 208, 1680\u20131685 (1969)","journal-title":"J.A.M.A."},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO;2-I","volume":"36","author":"R Alexanian","year":"1975","unstructured":"Alexanian, R., Balarzak, S., Boneet, J. D., Gehan, E. A., Haut, A., Hewlett, J. S., Monto, R. W. : Prognostic factors in multiple myeloma. Cancer 36, 1192\u20131201 (1975)","journal-title":"Cancer"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/bmj.4.5944.560","volume":"IV","author":"L Azam","year":"1974","unstructured":"Azam, L., Delamore, I. W. : Combination therapy for myelomatosis. Br. Med J. 1974, IV,560\u2013564","journal-title":"Br. Med J"},{"key":"5_CR7","first-page":"87","volume":"21","author":"DE Bergsagel","year":"1962","unstructured":"Bergsagel, D. E.: Evaluation of new chemotherapeutic agent in the treatment of multiple myeloma. IV. Phenylalanine mustard (NSC 8806). Cancer Chemother. Rep. 21, 87\u201399 (1962)","journal-title":"Cancer Chemother. Rep"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1126\/science.148.3668.376","volume":"148","author":"DE Bergsagel","year":"1965","unstructured":"Bergsagel, D. E.: Myeloma proteins and the clinical response to melphalan therapy. Science 148, 367\u2013377 (1965)","journal-title":"Science"},{"key":"5_CR9","first-page":"611","volume":"2","author":"J Bernard","year":"1962","unstructured":"Bernard, J., Seligmann, M., Danon, F.: Essai de traitement de 21 malades atteints de myelome ou de macroglobulin\u00e9mie par le pdi 2 chlor\u00e9thylaminolphenyl alanine (Melphalan). Nouv. Rev. Fr. Hematol. 2, 611\u2013616 (1962)","journal-title":"Nouv. Rev. Fr. Hematol"},{"key":"5_CR10","first-page":"817","volume":"37","author":"D Bontoux","year":"1970","unstructured":"Bontoux, D., Chenebit, D., Delbarre, F.: Essai d\u00e9tude comparative du melphalan et de la cyclophosphamide dans le traitement de la maladie de Kahler. Rev. Rhum. 37, 817\u2013824 (1970)","journal-title":"Rev. Rhum"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/1097-0142(1967)20:5<900::AID-CNCR2820200552>3.0.CO;2-Y","volume":"20","author":"N Brock","year":"1967","unstructured":"Brock, N., Hohorst, A. J. : Metabolism of cyclophosphamide. Cancer 20, 900\u2013904 (1967)","journal-title":"Cancer"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood.V30.3.265.265","volume":"30","author":"V Caggiano","year":"1967","unstructured":"Caggiano, V., Cuttner, J., Salomon, A.: Myeloma proteins. Bence Jones proteins and normal immunoglobulins in multiple myeloma. Blood 30, 265\u2013287 (1967)","journal-title":"Blood"},{"key":"5_CR13","doi-asserted-by":"crossref","unstructured":"Carbone, P. P., Kellerhouse, L. E., Gehan, E. A. : Plasmocytic myeloma: a study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Am. J. Med.42, 937\u2013949","DOI":"10.1016\/0002-9343(67)90074-5"},{"key":"5_CR14","first-page":"565","volume":"5","author":"A Chavaz","year":"1975","unstructured":"Chavaz, A., Mignon, F., Kanfer, A., Richet, G.: Traitement de l\u2019insuffisance r\u00e9nale du myelome multiple par l\u2019h\u00e9modialyse chronique. A propos de 4 cas. Nouv. Presse Med. 5, 565\u2013569 (1975)","journal-title":"Nouv. Presse Med"},{"key":"5_CR15","first-page":"12","volume":"4","author":"G Costa","year":"1963","unstructured":"Costa, G.: An assessment of L phenylalanine mustard in human multiple myeloma. Proc. Am. Assoc. Cancer Res. 4, 12 (1963)","journal-title":"Proc. Am. Assoc. Cancer Res"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0002-9343(73)90116-2","volume":"54","author":"G Costa","year":"1973","unstructured":"Costa, G., Engle, R. L., Schilling, A., Carbonne, P., Kochwa, S., Prognostic, R. L., Glidewell, O.: Melphalan and prednisone: an effective combination for the treatment of multiple myeloma. Am. J. Med. 54, 589\u2013599 (1973)","journal-title":"Am. J. Med"},{"key":"5_CR17","first-page":"537","volume":"121","author":"F Delbarre","year":"1970","unstructured":"Delbarre, F., Siguier, F., Godeau, P., Saporta, L., Seligman, M., Hurez, D.: La maladie de Kahler \u00e0 plasmocytes non excr\u00e9tants. Ann. Med. Interne. (Paris) 121, 537\u2013544 (1970)","journal-title":"Ann. Med. Interne. (Paris)"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJM197305102881905","volume":"288","author":"VT De Vita","year":"1973","unstructured":"De Vita, V. T., Schein, P. S. : The use of drugs in combination for the treatment of cancer: rationale and results. N. Engl. J. Med. 288, 998 (1973)","journal-title":"N. Engl. J. Med"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/1097-0142(197409)34:3<526::AID-CNCR2820340308>3.0.CO;2-R","volume":"34","author":"M Drewinko","year":"1974","unstructured":"Drewinko, M., Brown, B. W., Humphrey, R., Alexanian, R.: effect of chemotherapy on the labelling index of myeloma cells. Cancer 34, 526 (1974)","journal-title":"Cancer"},{"issue":"Suppl. 445","key":"5_CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.0954-6820.1966.tb02359.x","volume":"179","author":"A Drivsholm","year":"1966","unstructured":"Drivsholm, A., Videback, A.: Alkeran (melphalan) in the treatment of myelomatosis. Acta Med. Scand. 179.(Suppl. 445), 187\u2013193 (1966)","journal-title":"Acta Med. Scand"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"GM Durie","year":"1975","unstructured":"Durie, G. M., Salmon, S. E. : A clinical staging for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features. Response to treatment and survival. Cancer 36, 842\u2013854(1975)","journal-title":"Cancer"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/0002-9343(63)90140-2","volume":"35","author":"JL Fahey","year":"1963","unstructured":"Fahey, J. L., Scoggins, R. S., Utz, J. P., Szwed, C.: Infection, antibody response and gammaglobulin components in multiple myeloma and macroglobulinemia. Amer. J. Med. 35, 698\u2013707 (1963)","journal-title":"Amer. J. Med"},{"issue":"24","key":"5_CR23","first-page":"1259","volume":"I","author":"M Feinleib","year":"1960","unstructured":"Feinleib, M., Macmahon, B.: Duration or survival in multiple myeloma. J.N.C.I. 24, 1259\u20131269 (1960)","journal-title":"J.N.C"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/1097-0142(197206)29:6<1665::AID-CNCR2820290634>3.0.CO;2-4","volume":"29","author":"RP George","year":"1972","unstructured":"George, R. P., Poth, J. L., Gordon, D., Schrier, S. L. : Multiple myeloma intermittent combination chemotherapy compared to continuous therapy. Cancer 29, 1665\u20131670 (1972)","journal-title":"Cancer"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/jama.1969.03160150037009","volume":"209","author":"B Hoogstraten","year":"1967","unstructured":"Hoogstraten, B., Costa, J.: Intermittent melphalan therapy in multiple myeloma. J.A.M.A. 209, 251\u2013253 (1967)","journal-title":"J.A.M.A."},{"key":"5_CR26","volume-title":"On a new substance occurring in the urine of a patient with urollitics ossium. Philos","author":"HB Jones","year":"1848","unstructured":"Jones, H. B.: On a new substance occurring in the urine of a patient with urollitics ossium. Philos, Trans. R. Soc. Lond. (Biol. Sci.) 55\u201362 (1848)"},{"key":"5_CR27","first-page":"33","volume":"14","author":"O Kahler","year":"1889","unstructured":"Kahler, O.: Zur Symptomatologik des multiplen Myeloms: Beobachtung von Albumosurie. Prag. Med. (Wochenscht.) 14, 33\u201335 (1889)","journal-title":"Prag. Med. (Wochenscht.)"},{"key":"5_CR28","first-page":"990","volume":"62","author":"DR Korst","year":"1963","unstructured":"Korst, D. R., Wilson, H. E., Fowler, W. M., Will, J. R., Clifford, G. O., Louis, J.. Treatment of multiple myeloma. An analysis of cyclophosphamide (Cytoxan) therapy in 170 patients. J. LAb. Clin. Med. 62 990(1963)","journal-title":"J. LAb. Clin. Med"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/jama.1964.03070100052010","volume":"189","author":"DR Korst","year":"1964","unstructured":"Korst, D. R., Clifford, G. O., Fowler, W. M., Louis, J., Will, J., Wilson, H. E. : Multiple myeloma. II. Analysis of cyclophosphamide therapy in 165 Patients. J.A.M.A. 189, 758\u2013762 (1964)","journal-title":"J.A.M.A."},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/1097-0142(197402)33:2<533::AID-CNCR2820330231>3.0.CO;2-Z","volume":"33","author":"BJ Lee","year":"1974","unstructured":"Lee, B. J., Sahakian, G., Clarkson, B. D., Krakoff, I. H. : Combination chemotherapy of multiple myeloma with alkeran, Cytoxan, vincristine, prednisone and BCNU. Cancer 33, 533\u2013538 (1974)","journal-title":"Cancer"},{"key":"5_CR31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-77-2-239","volume":"77","author":"SH Lee","year":"1972","unstructured":"Lee, S. H., Polesky, H. F., Shapiro, F. L. : Chronic hemodialysis in myelomatosis. Ann. Intern. Med. 77, 239\u2013242(1972)","journal-title":"Ann. Intern. Med"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1084\/jem.116.6.859","volume":"116","author":"M Mannik","year":"1962","unstructured":"Mannik, M., Kunkel, H. G. : Classification of myeloma proteins, Bence Jones proteins and macroglobulins into two groups on the basis of common antigenic characters. J. Exp. Med. 116, 859- 877 (1962)","journal-title":"J. Exp. Med."},{"key":"5_CR33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3181\/00379727-147-38382","volume":"147","author":"GM Mavligit","year":"1974","unstructured":"Mavligit, G. M., Gutterman, J. U., Hersh, E. M., Alexanian, R.: Cell mediated immunity to plasma cell myeloma: specific inhibition by a serum factor adhering to effector lymphocytes (38382). Proc. Soc. Exp. Biol. Med. 147, 537\u2013540 (1974)","journal-title":"Proc. Soc. Exp. Biol. Med"},{"key":"5_CR34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/0003-4819-72-5-665","volume":"72","author":"JR McArthur","year":"1970","unstructured":"McArthur, J. R., Athens, J. W., Wintrob, M. M., Cartwright, G. E. : Melphalan and myeloma. Experience with a low-dose continuous regimen. Ann. Intern. Med. 72, 665\u2013670 (1970)","journal-title":"Ann. Intern. Med"},{"key":"5_CR35","first-page":"640","volume":"I","author":"Medical Research Council, London WIN 4AL","year":"1971","unstructured":"Medical Research Council, London WIN 4AL: Report of the medical research council\u2019s working party for therapeutic trials in leukemia. Myelomatosis: comparison of melphalan and cyclophosphamide therapy. Br. Med. J. 1971 I, 640\u2013641","journal-title":"Br. Med. J."},{"key":"5_CR36","first-page":"2301","volume":"75","author":"G Meshak","year":"1967","unstructured":"Meshak, G., Seligman, M., Jacquillat, C., Basch, A., Bernard, J.: Le traitement du myelome multiple par le melphalan. Presse Med. 75, 2301\u20132306 (1967)","journal-title":"Presse Med"},{"key":"5_CR37","first-page":"13.","volume-title":"Multiple Myeloma: Beneficial Effects of Acute Infectious or Immunotherapy (Bacterial Vaccines). Monograph","author":"HC Nauts","year":"1975","unstructured":"Nauts, H. C.: Multiple Myeloma: Beneficial Effects of Acute Infectious or Immunotherapy (Bacterial Vaccines). Monograph 13. New York: Cancer Research Institute Inc. 1975"},{"key":"5_CR38","first-page":"1","volume":"9","author":"EE Osgood","year":"1960","unstructured":"Osgood, E. E.: The survival time of patients with plasmocytic myeloma. Cancer Chemother. Rep. 9, 1\u201310 (1960)","journal-title":"Cancer Chemother. Rep"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.0954-6820.1961.tb00273.x","volume":"170","author":"F Paraskevas","year":"1961","unstructured":"Paraskevas, F., Heremans, J., Waldenstrom, J.: Cytology and electrophoretic pattern in yla 052a) myeloma. Acta Med. Scand. 170, 575\u2013589 (1961)","journal-title":"Acta Med. Scand"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1001\/jama.1969.03150200094011","volume":"207","author":"SL Rivers","year":"1969","unstructured":"Rivers, S. L., Patno, M.E.: Cyclophosphamide vs melphalan in treatment of plasma cell myeloma. J.A.M.A. 207, 1328\u20131334 (1969)","journal-title":"J.A.M.A."},{"key":"5_CR41","first-page":"115","volume":"29","author":"SL Rivers","year":"1963","unstructured":"Rivers, S. L., Whittington, R. M., Patno, M. E. : Cyclophosphamide in treatment of multiple myeloma. Cancer Chemother. Rep. 29, 115\u2013119 (1963)","journal-title":"Cancer Chemother. Rep"},{"key":"5_CR42","first-page":"115","volume":"29","author":"SL Rivers","year":"1963","unstructured":"Rivers, S. L., Whittington, R. M., Patno, M. E. : Comparison of effect of cyclophosphamide and a placebo in treatment of multiple myeloma. Cancer Chemother. Rep. 29, 115\u2013119 (1963)","journal-title":"Cancer Chemother. Rep"},{"key":"5_CR43","first-page":"11","volume":"39","author":"L Saporta","year":"1972","unstructured":"Saporta, L., Hugon, C., Rondier, J., Bontoux, D., Delbarre, F.: Pronostic de la maladie de Kalher chez des patients trait\u00e9s ou non par les agents alkylants (\u00e0 propos de 45 cas), rev. Rhum. 39, 11\u201318 (1972)","journal-title":"Rhum"},{"key":"5_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1182\/blood.V45.1.119.119","volume":"45","author":"SE Salmon","year":"1975","unstructured":"Salmon, S. E.: Expansion of the growth fraction in multiple myeloma with alkylating agents. Blood 45, 119\u2013129(1975)","journal-title":"Blood"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1172\/JCI106327","volume":"49","author":"SE Salmon","year":"1970","unstructured":"Salmon, S. E., Smith, B. A. : Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J. Clin. Invest. 49, 1114\u20131121 (1970)","journal-title":"J. Clin. Invest"},{"key":"5_CR46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4049\/jimmunol.104.3.665","volume":"104","author":"SE Salmon","year":"1970","unstructured":"Salmon, S. E., Smith, B. A. : Sandwich solid phase radioimmunoassays for the characterization of human immunoglobulins synthesized in vitro. J. Immunol. 104, 665 (1970)","journal-title":"J. Immunol"},{"key":"5_CR47","first-page":"570","volume":"20","author":"SE Salmon","year":"1972","unstructured":"Salmon, S. E., Smith, B. A. : Induction of tumor susceptibility to cycle active agents in IgG multiple myeloma. Clin. Res. 20, 570 (1972)","journal-title":"Clin. Res"},{"key":"5_CR48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V21.4.403.403","volume":"21","author":"A Salomon","year":"1963","unstructured":"Salomon, A., Fahey, J. L., Malmgren, R. A. : Immunohistologic localization of gamma 1 macroglobulins Beta 2A myeloma proteins 6.6S gamma-myeloma proteins and Bence-Jones protein. Blood 21, 403\u2013423 (1963)","journal-title":"Blood"},{"key":"5_CR49","first-page":"1964","volume":"I","author":"DE Speed","year":"1664","unstructured":"Speed, D. E., Galton, D. A. G., Swan, A.: Melphalan in the treatment of myelomatosis. Br. Med. J. 1964 I, 1664","journal-title":"Br. Med. J"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1172\/JCI106971","volume":"51","author":"PW Sullivan","year":"1972","unstructured":"Sullivan, P. W., Salmon, S. E. : Kinetics of tumor growth and regression in IgG multiple myeloma. J. Clin. Invest. 51, 1697\u20131708 (1972)","journal-title":"J. Clin. Invest"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/BF02911073","volume":"3","author":"J von Rustizky","year":"1873","unstructured":"Rustizky, J. von: Multiple myelom. Dtsch. Chir. 3, 162\u2013172 (1873)","journal-title":"Dtsch. Chir"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/bmj.1.5387.859","volume":"I","author":"J Waldenstrom","year":"1964","unstructured":"Waldenstrom, J.: Melphalan therapy in myelomatosis. Br. Med. J. 1964 I, 859\u2013865","journal-title":"Br. Med. J"},{"key":"5_CR53","first-page":"1334","volume":"23","author":"GP Wheller","year":"1963","unstructured":"Wheller, G. P.: Studies related to mechanisms of resistance to biological alkylating agents. Cancer Res. 23, 1334(1963)","journal-title":"Cancer Res"},{"key":"5_CR54","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.7326\/0003-4819-41-6-1152","volume":"41","author":"HH Zinneman","year":"1954","unstructured":"Zinneman, H. H., Hall, W. H. : Recurrent pneumonia in multiple myeloma and some observations on immunologic response. Ann. Intern. Med. 41, 1152\u20131163 (1954)","journal-title":"Ann. Intern. Med"}],"container-title":["Recent Results in Cancer Research","Lymphoid Neoplasias II"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-81249-1_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T19:44:49Z","timestamp":1713383089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-81249-1_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978]]},"ISBN":["9783642812514","9783642812491"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-81249-1_5","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1978]]}}}